Our broad-based transaction experience extends across a range of situations, industries and enterprise values
Categories
Year
Type
Industry
Announced: May 31, 2022Value: €40 billionStatus: PendingFinancial advisor to DSM on its merger with Firmenich
Announced: May 10, 2022Value: $12.5 billionStatus: PendingExclusive financial advisor to Biohaven Pharmaceuticals on its sale to Pfizer Inc. and pro rata distribution of shares in a new publicly traded biopharma company
Announced: February 1, 2022Value: $8 billionStatus: PendingExclusive investment banker to a group of ad hoc lenders throughout Intelsat's chapter 11 proceedings, including a refinancing of existing secured debt and DIP facilities
Announced: February 14, 2022Value: $5.9 billionStatus: PendingFinancial advisor to the Special Committee of Cornerstone's Board of Directors on the sale of shares to Clayton, Dubilier & Rice that CD&R did not already own
Announced: August 8, 2022Value: $5.8 billionStatus: PendingFinancial advisor to Global Blood Therapeutics on its sale to Pfizer
Announced: May 31, 2022Value: €3.85 billionStatus: PendingFinancial advisor to DSM on the sale of its DSM Engineering Materials business to a newly incorporated joint venture owned by Advent International and LANXESS AG
Announced: January 10, 2022Value: $4.1 billionStatus: PendingLead financial advisor to R1 on its acquisition of Cloudmed
Announced: May 31, 2022Value: Up to $3.3 billionStatus: PendingFinancial advisor to Affinivax on its sale to GSK plc
Announced: February 10, 2022Value: £1.9 billionStatus: ClosedFinancial advisor to Informa on the divestiture of its Pharma Intelligence business to Warburg Pincus
Announced: April 1, 2022Value: €1.5 billionStatus: PendingFinancial advisor to the LFP on the sale of a 13% minority stake in its newly-created MediaCo subsidiary to CVC
Announced: April 4, 2022Value: $1.9 billionStatus: PendingExclusive financial advisor to Pensando on its acquisition by Advanced Micro Devices
Announced: April 20, 2022Value: €1.44 billionStatus: PendingFinancial advisor to DSM on its divestiture of its DSM Protective Materials business to Avient Corporation
Announced: June 30, 2022Value: $1.5 billionStatus: PendingExclusive financial advisor to the Special Committee of the Board of Directors of Constellation in connection with the reclassification of Constellation's Class B common stock
Announced: April 18, 2022Value: €1.075 billionStatus: PendingFinancial advisor to I2PO, a Special Purpose Acquisition Company (SPAC) on its acquisition of Deezer
Announced: June 21, 2022Value: $1.1 billionStatus: PendingSole financial advisor to the Special Committee of the Board of Directors of Convey on the sale of remaining shares not currently owned by TPG Capital to TPG
Announced: April 22, 2022Value: $900 millionStatus: PendingExclusive financial advisor to Stanley on the divestiture of Access Technologies, its automatic doors business, to Allegion plc
Announced: March 31, 2022Value: €675 millionStatus: PendingFinancial advisor to 2MX Organic, a Special Purpose Acquisition Company (SPAC), on its combination with InVivo Retail
Announced: February 7, 2022Value: $593 millionStatus: PendingExclusive financial advisor to Resideo on its acquisition of First Alert, Inc. from Newell Brands Inc.
Announced: June 15, 2022Value: $575 millionStatus: PendingExclusive investment banker to the BrandCo Ad-Hoc Group in connection with Revlon's chapter 11 filing with the support of a debtor-in-possession financing provided by BrandCo lenders
Announced: April 7, 2022Value: Up to $525 millionStatus: PendingFinancial advisor to ReViral on its sale to Pfizer Inc.
Announced: June 10, 2022Value: $500 millionStatus: PendingFinancial advisor to DGI on its balance sheet refinancing for its Burger King, Popeyes and La Madeleine operations
Announced: May 16, 2022Value: Up to $337 millionStatus: PendingExclusive financial advisor to Chimerix on its sale of exclusive worldwide rights to brincidofovir, including TEMBEXA, to Emergent BioSolutions
Announced: July 11, 2022Value: $320 millionStatus: PendingExclusive financial advisor to ViaCyte on its acquisition by Vertex Pharmaceuticals, Inc.
Announced: January 27, 2022Value: $305 millionStatus: PendingFinancial advisor to Oscar on its exploration of strategic financing alternatives and sole placement agent on a private placement of convertible senior notes led by Dragoneer Investment Group
Announced: April 20, 2022Value: $280 millionStatus: PendingExclusive financial advisor to PTC on its acquisition of Intland Software
Announced: April 19, 2022Value: $250 millionStatus: PendingExclusive financial advisor to Checkmate on its sale to Regeneron Pharmaceuticals
Announced: June 13, 2022Value: $200 millionStatus: PendingExclusive financial advisor to Cornerstone, a portfolio company of Clearlake Capital, on its acquisition of SumTotal, a subsidiary of Skillsoft
Announced: July 19, 2022Value: $193 millionStatus: PendingFinancial advisor to Informa on its divestiture of EPFR Global to Montagu
Announced: May 10, 2022Value: £119 millionStatus: PendingFinancial advisor to Diageo on its sale of Picon to Campari Group
Announced: May 9, 2022Value: $150 millionStatus: ClosedExclusive financial advisor to ServiceSource on its acquisition by Concentrix Corporation
Announced: July 13, 2022Status: PendingInvestment banker to Celsius on its initiation of voluntary chapter 11 proceedings
Announced: July 6, 2022Status: ClosedFinancial advisor to North Road on its combination of Chernin Entertainment, the US assets of Red Arrow Studios and Words + Pictures, in addition to an equity investment by Providence Equity Partners and debt financing from Apollo Advisors
Announced: June 30, 2022Status: PendingExclusive financial advisor to Enjoy on its chapter 11 filing with debtor-in-possession financing provided by Asurion and connected letter of intent for Asurion to acquire substantially all of Enjoy's U.S. assets through a 363 sale process
Announced: June 29, 2022Status: PendingLead financial advisor to Joseph Phelps on its sale to Moët Hennessy, a division of LVMH
Announced: June 22, 2022Status: ClosedFinancial advisor to eBay on its acquisition of KnownOrigin
Announced: June 21, 2022Status: PendingFinancial advisor to Accor on its sale of a 10.8% interest in Ennismore to Qatar First Bank
Announced: May 26, 2022Status: ClosedSole financial advisor to McDonald's in connection with its proxy contest with Icahn Enterprises
Announced: May 10, 2022Status: PendingFinancial advisor to US Foods on its engagement with Sachem Head
Announced: April 21, 2022Status: ClosedFinancial advisor and investment banker to MediaMath on its comprehensive recapitalization in partnership with Searchlight
Announced: April 21, 2022Status: PendingFinancial Advisor to Synovus on its strategic investment to acquire 60% of Qualpay
Announced: March 9, 2022Status: PendingExclusive financial advisor to Vauban on its purchase of equity in Paprec Group
Announced: February 24, 2022Status: ClosedExclusive financial advisor to Kimberly-Clark on its acquisition of a majority stake in Thinx, Inc.
Announced: February 18, 2022Status: ClosedExclusive financial advisor to Recipharm on its acquisition of Vibalogics
Announced: February 18, 2022Status: ClosedExclusive financial advisor to Recipharm on its acquisition of Arranta Bio
Announced: February 14, 2022Status: ClosedLead financial advisor to Resonant on its purchase by Murata Manufacturing Co., Ltd.
Announced: February 11, 2022Status: ClosedFinancial advisor to Ole Smoky on its sale to Apax Partners
Announced: February 9, 2022Status: PendingExclusive financial advisor to Thirty Madison on its merger with Nurx
Announced: February 7, 2022Status: PendingExclusive financial advisor to Jacobs on its acquisition of StreetLight Data, Inc.